Abstract:Antimicrobial peptides are short cationic peptides that are present on biological surfaces susceptible to infection, and they play an important role in innate immunity. These peptides, like other compounds with antimicrobial activity, often have significant superoxide dismutase (SOD) activity. One direction of our research is the characterization of peptides modeling the CuZnSOD enzyme and the determination of their biological activity, and these results may contribute to the development of novel antimicrobial peptides. In the framework of this research, we have synthesized 10, 15, and 16-membered model peptides containing the amino acid sequence corresponding to the Cu(II) and Zn(II) binding sites of the CuZnSOD enzyme, namely the Zn(II)-binding HVGD sequence (80–83. fragments), the Cu(II)-binding sequence HVH (fragments 46–48), and the histidine (His63), which links the two metal ions as an imidazolate bridge: Ac-FHVHEGPHFN-NH2 (L1(10)), Ac-FHVHAGPHFNGGHVG-NH2 (L2(15)), and Ac-FHVHEGPHFNGGHVGD-NH2 (L3(16)). pH-potentiometric, UV-Vis-, and CD-spectroscopy studies of the Cu(II), Zn(II), and Cu(II)-Zn(II) mixed complexes of these peptides were performed, and the SOD activity of the complexes was determined. The binding sites preferred by Cu(II) and Zn(II) were identified by means of CD-spectroscopy. From the results obtained for these systems, it can be concluded that in equimolar solution, the –(NGG)HVGD- sequence of the peptides is the preferred binding site for copper(II) ion. However, in the presence of both metal ions, according to the native enzyme, the -HVGD- sequence offers the main binding site for Zn(II), while the majority of Cu(II) binds to the -FHVH- sequence. Based on the SOD activity assays, complexes of the 15- and 16-membered peptide have a significant SOD activity. Although this activity is smaller than that of the native CuZnSOD enzyme, the complexes showed better performance in the degradation of superoxide anion than other SOD mimics. Thus, the incorporation of specific amino acid sequences mimicking the CuZnSOD enzyme increases the efficiency of model systems in the catalytic decomposition of superoxide anion.

The Effect of Complexation of Cu(II) with P6A Peptide and Its Analogs on Their Thrombolytic Activities

Coordination of Thrombolytic Pro-Ala-Lys Peptides with Cu (II): Leading to Nanoscale Self-assembly, Increase of Thrombolytic Activity and Additional Vasodilation

Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing l-Arg and l-Asp or l-Glu

The Composition and Sequence Specificity of Pro-Ala-Lys-OH for the Thrombolytic Activities of P6A and Related Oligopeptides

Synthesis and Thrombolytic Activity of Pseudopeptides Related to Fibrinogen Fragment

Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets

Anticoagulant, Anti-Aggregation and Antithrombotic Effects of a Novel Hexapeptide

Synthesis, Nanofeatures, in Vitro Thrombus Lysis Activity and in Vivo Thrombolytic Activity of Poly-Alpha,Beta-Aspartyl-L-Alanine

Effects of hexapeptide on human platelet aggregation activity

Synthesis, crystal structures, molecular docking and in vitro cytotoxicity studies of two new copper(II) complexes: special emphasis on their binding to HSA

Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy

Identification and Inhibitory Activity Against Α-Thrombin of a Novel Anticoagulant Peptide Derived from Oyster (crassostrea Gigas) Protein

Effects of the tetravanadate [V4O12]4− anion on the structural, magnetic, and biological properties of copper/phenanthroline complexes

Synthesis and Thrombolytic Activity of Carboline-3-carboxylic Acid Modified Metabolites of Ala-Arg-Pro-Ala-Lys.

Characterization of Copper(II) and Zinc(II) Complexes of Peptides Mimicking the CuZnSOD Enzyme

Two Cu(II) Complexes Containing 2,4-Diamino-6-(2-pyridyl)-1,3,5-triazine and Amino Acids: Synthesis, Crystal Structures, DNA/HSA Binding, Molecular Docking, and in Vitro Cytotoxicity Studies

RGD Modified Protein-Polymer Conjugates for Ph-Triggered Targeted Thrombolysis

Interactions of disulfide-constrained cyclic tetrapeptides with Cu(2+)

Polyphenol‐Functionalized Cubosomes as Thrombolytic Drug Carriers

Effects of Cu 2+ on Aggregation Behavior of Poly ( L -Glutamic Acid)-functionalized Gold Nanoparticles

Anticoagulant Dodecapeptide Suppresses Thrombosis in Vivo by Inhibiting the Thrombin Exosite-I Binding Site.